Nile Therapeutics, Inc. Reports 2009 Fourth Quarter and Full Year Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Nile Therapeutics, Inc. (NASDAQ:NLTX), a biopharmaceutical company in the development of novel therapeutics for heart failure patients, today announced its fourth quarter and full year financial results for 2009. The company will host a conference call and live webcast to discuss these financial results and provide an update on each of its development programs at 8:30 a.m. EST on March 5, 2010. Interested investors may participate in the conference call by dialing +1-877-303-6918 (USA) or +1-973-638-3210 (international). Participants may also access both the live and archived webcast of the conference call from the homepage and the investor relations section of Nile’s website at www.nilethera.com.

MORE ON THIS TOPIC